M&A Deal Summary |
|
---|---|
Date | 2015-01-01 |
Target | Green Cross Biotherapeutics |
Sector | Life Science |
Buyer(s) | Stonebridge Capital |
Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 2008 |
PE ASSETS | 118M KRW |
Size | Small |
Type | Sector Agnostic |
Stonebridge Capital is a Korean private equity and venture capital firm focused on investing in growth businesses at all company stages. Stonebridge looks for businesses that have the potential to be market leaders. Sectors of interest include consumer goods, value-added manufacturing, media/entertainment, healthcare, financial services, business services, real estate, and oil/gas exploration. The Firm generally targets businesses operating in Korea, China, and Japan. Stonebridge Capital was formed in 2008 and is based in Seoul.
DEAL STATS | # |
---|---|
Overall | 8 of 8 |
Sector (Life Science) | 1 of 1 |
Type (Buyout (LBO, MBO, MBI)) | 1 of 1 |
State (Quebec) | 1 of 1 |
Country (Canada) | 1 of 1 |
Year (2015) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-12-31 |
SK Incheon Petrochem
Incheon, South Korea SK Incheon Petrochem Co.,Ltd. provides oil and gas services. |
Buy | - |